STOCK TITAN

aiki - $aiki STOCK NEWS

Welcome to our dedicated page for aiki news (Ticker: $aiki), a resource for investors and traders seeking the latest updates and insights on aiki stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect aiki's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of aiki's position in the market.

Rhea-AI Summary
Dominari Holdings Inc. CEO Kyle Wool appeared on Fox Business' 'The Claman Countdown' to discuss sectors with pre-IPO potential and investment opportunities. Dominari Securities is a boutique investment bank. Replay of the interview available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.02%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.89%
Tags
none
-
Rhea-AI Summary
DatChat provides update on $2 million share repurchase program
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.67%
Tags
buyback
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.24%
Tags
management
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.49%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.62%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.26%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
buyback
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
aiki

Nasdaq:AIKI

AIKI Rankings

AIKI Stock Data

19.53M
Payroll Services
Professional, Scientific, and Technical Services
Link
US
New York

About AIKI

AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipeline to treat unmet medical needs in oncology. The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus.